Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes

BACKGROUND: Ovarian stimulation for IVF profoundly alters the early luteal phase endometrial development. It has been hypothesized that this process has already started in the late follicular phase, as the endometrium has already been exposed to high steroid concentrations since that phase. The aim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human reproduction (Oxford) 2005-06, Vol.20 (6), p.1541-1547
Hauptverfasser: Papanikolaou, Evangelos G., Bourgain, Claire, Kolibianakis, Efstratios, Tournaye, Herman, Devroey, Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1547
container_issue 6
container_start_page 1541
container_title Human reproduction (Oxford)
container_volume 20
creator Papanikolaou, Evangelos G.
Bourgain, Claire
Kolibianakis, Efstratios
Tournaye, Herman
Devroey, Paul
description BACKGROUND: Ovarian stimulation for IVF profoundly alters the early luteal phase endometrial development. It has been hypothesized that this process has already started in the late follicular phase, as the endometrium has already been exposed to high steroid concentrations since that phase. The aim of the present study was to prospectively investigate the effect of multi-follicular ovarian stimulation for IVF on the late follicular phase endometrium histology and the expression of estrogen receptor (ER) and progesterone receptor (PR). METHODS: In a cross-over study, 11 infertile women with normal ovulatory function, participating in an IVF programme and treated with GnRH antagonist/recombinant FSH ovarian stimulation, were enrolled in the study. Endometrial biopsies were taken in a natural cycle on the day of the onset of the surge of the LH, and in a subsequent stimulation cycle on the day of hCG administration for final oocyte maturation. Endometrial histological dating was carried out according to Noyes' criteria. Immunohistochemistry was performed, using commercially available antibodies for ER and PR endometrial expression. The immunohistochemical signal was recorded in 1000 epithelial cells in each compartment (glands and stroma). Endometrial expression for each of the two receptors was graded on a scale of 0–3, based on the intensity of nuclear staining. Then a score range between 0 and 3000 was recorded, and expressed as a mean score per 1000 stroma or glandular cells per sample (range: 0–3). RESULTS: Histological examination of biopsies both in natural and stimulated cycles showed no secretory changes. However, in stimulated cycles, PR expression was significantly up-regulated compared to natural cycles in both glands (1.67 versus 1.34, P
doi_str_mv 10.1093/humrep/deh793
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67843422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/deh793</oup_id><sourcerecordid>857801441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-6136f46dce066289611b6f0554db5d78f5e28616b0d0eae48c8cd34f2458ba613</originalsourceid><addsrcrecordid>eNqFkUtv1DAUhSMEokNhyRZZSCAWhNp5OJ5lVdFOpVLEUxWbyLFvZlwcO9iO1PmZ_CPuKBGV2LC6Z_Gde659suw5o-8YXZcnu2kIMJ5o2DXr8kG2YhWneVHW9GG2ogUXOWOcHWVPYrylFKXgj7MjVje0Rr3Kfn9JELzRJICCMflA4G4MEKPxjhhHrExAem-tUZOVgYw7GYGA036AFMw0HKAL93lDpEty652JiVx-PydqryxEYiKRNoDUe5wYBfotOrRRMhm3RWmSQYlhvicgg90TOyWQdklKQbrY-zDMEIalHRDZRXAKDp4IKgDevSdqJ90W4tPsUS9thGfLPM6-nb__erbJrz5eXJ6dXuWqqkXKOSt5X3GtgHJeiDVnrOM9retKd7VuRF9DITjjHdUUJFRCCaXLqi_Q3Ul0H2ev571j8L8miKkdTFRgrXTgp9jyRlRlVRQIvvwHvPVTcHhbWzAmGl4XHKF8hlTwMQbo2zGYQYZ9y2h7KLqdi27nopF_sSydugH0Pb00i8CrBZBRSdvjPyoT7zkuKooocm9mzk_jfzOXG7FjuPsLy_ATH1s2dbu5-dGur6-vxacPtL0p_wCWUNT5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211876526</pqid></control><display><type>article</type><title>Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Papanikolaou, Evangelos G. ; Bourgain, Claire ; Kolibianakis, Efstratios ; Tournaye, Herman ; Devroey, Paul</creator><creatorcontrib>Papanikolaou, Evangelos G. ; Bourgain, Claire ; Kolibianakis, Efstratios ; Tournaye, Herman ; Devroey, Paul</creatorcontrib><description>BACKGROUND: Ovarian stimulation for IVF profoundly alters the early luteal phase endometrial development. It has been hypothesized that this process has already started in the late follicular phase, as the endometrium has already been exposed to high steroid concentrations since that phase. The aim of the present study was to prospectively investigate the effect of multi-follicular ovarian stimulation for IVF on the late follicular phase endometrium histology and the expression of estrogen receptor (ER) and progesterone receptor (PR). METHODS: In a cross-over study, 11 infertile women with normal ovulatory function, participating in an IVF programme and treated with GnRH antagonist/recombinant FSH ovarian stimulation, were enrolled in the study. Endometrial biopsies were taken in a natural cycle on the day of the onset of the surge of the LH, and in a subsequent stimulation cycle on the day of hCG administration for final oocyte maturation. Endometrial histological dating was carried out according to Noyes' criteria. Immunohistochemistry was performed, using commercially available antibodies for ER and PR endometrial expression. The immunohistochemical signal was recorded in 1000 epithelial cells in each compartment (glands and stroma). Endometrial expression for each of the two receptors was graded on a scale of 0–3, based on the intensity of nuclear staining. Then a score range between 0 and 3000 was recorded, and expressed as a mean score per 1000 stroma or glandular cells per sample (range: 0–3). RESULTS: Histological examination of biopsies both in natural and stimulated cycles showed no secretory changes. However, in stimulated cycles, PR expression was significantly up-regulated compared to natural cycles in both glands (1.67 versus 1.34, P&lt;0.05) and stroma (1.98 versus 1.62, P&lt;0.05), whereas ER was down-regulated in glands (1.15 versus 1.43, P&lt;0.05). In IVF cycles, the progesterone measurements, although within normal values (range 0.8–1.4 µg/l), were significantly higher than in natural cycles (0.99 vs 0.63 µg/l, respectively, P=0.008). An ongoing pregnancy rate of 37.5% was achieved in the stimulated cycles. DISCUSSION: Although the current study found no early secretory transformation in stimulated endometria before hCG administration, the ER and PR expression in these endometria is similar to the one described during the first days of the luteal phase in natural cycles. Supraphysiological concentrations of estradol and subtle progesterone rises in the late follicular phase might be responsible for this modulated steroid receptor profile. This phenomenon indicates accentuated maturation of the endometrium in IVF cycles from the pre-ovulatory phase onwards.</description><identifier>ISSN: 0268-1161</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/deh793</identifier><identifier>PMID: 15705618</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Biological and medical sciences ; Chorionic Gonadotropin - therapeutic use ; endometrial receptivity ; Endometrium - drug effects ; Endometrium - pathology ; Endometrium - physiology ; estrogen receptor ; Female ; Fertilization in Vitro - methods ; Follicle Stimulating Hormone - therapeutic use ; Follicular Phase - drug effects ; Follicular Phase - physiology ; GnRH antagonist ; Gonadotropin-Releasing Hormone - antagonists &amp; inhibitors ; Gynecology. Andrology. Obstetrics ; Humans ; Luteal Phase - drug effects ; Luteal Phase - physiology ; Luteinizing Hormone - blood ; Medical sciences ; Ovulation Induction - methods ; pre-ovulatory endometrium ; Pregnancy ; Pregnancy Outcome ; Pregnancy Rate ; progesterone receptor ; Prospective Studies ; Receptors, Steroid - drug effects ; Receptors, Steroid - metabolism ; Reference Values</subject><ispartof>Human reproduction (Oxford), 2005-06, Vol.20 (6), p.1541-1547</ispartof><rights>The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org 2005</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Jun 1, 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-6136f46dce066289611b6f0554db5d78f5e28616b0d0eae48c8cd34f2458ba613</citedby><cites>FETCH-LOGICAL-c458t-6136f46dce066289611b6f0554db5d78f5e28616b0d0eae48c8cd34f2458ba613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16840705$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15705618$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Papanikolaou, Evangelos G.</creatorcontrib><creatorcontrib>Bourgain, Claire</creatorcontrib><creatorcontrib>Kolibianakis, Efstratios</creatorcontrib><creatorcontrib>Tournaye, Herman</creatorcontrib><creatorcontrib>Devroey, Paul</creatorcontrib><title>Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes</title><title>Human reproduction (Oxford)</title><addtitle>Hum. Reprod</addtitle><addtitle>Hum. Reprod</addtitle><description>BACKGROUND: Ovarian stimulation for IVF profoundly alters the early luteal phase endometrial development. It has been hypothesized that this process has already started in the late follicular phase, as the endometrium has already been exposed to high steroid concentrations since that phase. The aim of the present study was to prospectively investigate the effect of multi-follicular ovarian stimulation for IVF on the late follicular phase endometrium histology and the expression of estrogen receptor (ER) and progesterone receptor (PR). METHODS: In a cross-over study, 11 infertile women with normal ovulatory function, participating in an IVF programme and treated with GnRH antagonist/recombinant FSH ovarian stimulation, were enrolled in the study. Endometrial biopsies were taken in a natural cycle on the day of the onset of the surge of the LH, and in a subsequent stimulation cycle on the day of hCG administration for final oocyte maturation. Endometrial histological dating was carried out according to Noyes' criteria. Immunohistochemistry was performed, using commercially available antibodies for ER and PR endometrial expression. The immunohistochemical signal was recorded in 1000 epithelial cells in each compartment (glands and stroma). Endometrial expression for each of the two receptors was graded on a scale of 0–3, based on the intensity of nuclear staining. Then a score range between 0 and 3000 was recorded, and expressed as a mean score per 1000 stroma or glandular cells per sample (range: 0–3). RESULTS: Histological examination of biopsies both in natural and stimulated cycles showed no secretory changes. However, in stimulated cycles, PR expression was significantly up-regulated compared to natural cycles in both glands (1.67 versus 1.34, P&lt;0.05) and stroma (1.98 versus 1.62, P&lt;0.05), whereas ER was down-regulated in glands (1.15 versus 1.43, P&lt;0.05). In IVF cycles, the progesterone measurements, although within normal values (range 0.8–1.4 µg/l), were significantly higher than in natural cycles (0.99 vs 0.63 µg/l, respectively, P=0.008). An ongoing pregnancy rate of 37.5% was achieved in the stimulated cycles. DISCUSSION: Although the current study found no early secretory transformation in stimulated endometria before hCG administration, the ER and PR expression in these endometria is similar to the one described during the first days of the luteal phase in natural cycles. Supraphysiological concentrations of estradol and subtle progesterone rises in the late follicular phase might be responsible for this modulated steroid receptor profile. This phenomenon indicates accentuated maturation of the endometrium in IVF cycles from the pre-ovulatory phase onwards.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Chorionic Gonadotropin - therapeutic use</subject><subject>endometrial receptivity</subject><subject>Endometrium - drug effects</subject><subject>Endometrium - pathology</subject><subject>Endometrium - physiology</subject><subject>estrogen receptor</subject><subject>Female</subject><subject>Fertilization in Vitro - methods</subject><subject>Follicle Stimulating Hormone - therapeutic use</subject><subject>Follicular Phase - drug effects</subject><subject>Follicular Phase - physiology</subject><subject>GnRH antagonist</subject><subject>Gonadotropin-Releasing Hormone - antagonists &amp; inhibitors</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Luteal Phase - drug effects</subject><subject>Luteal Phase - physiology</subject><subject>Luteinizing Hormone - blood</subject><subject>Medical sciences</subject><subject>Ovulation Induction - methods</subject><subject>pre-ovulatory endometrium</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Pregnancy Rate</subject><subject>progesterone receptor</subject><subject>Prospective Studies</subject><subject>Receptors, Steroid - drug effects</subject><subject>Receptors, Steroid - metabolism</subject><subject>Reference Values</subject><issn>0268-1161</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1DAUhSMEokNhyRZZSCAWhNp5OJ5lVdFOpVLEUxWbyLFvZlwcO9iO1PmZ_CPuKBGV2LC6Z_Gde659suw5o-8YXZcnu2kIMJ5o2DXr8kG2YhWneVHW9GG2ogUXOWOcHWVPYrylFKXgj7MjVje0Rr3Kfn9JELzRJICCMflA4G4MEKPxjhhHrExAem-tUZOVgYw7GYGA036AFMw0HKAL93lDpEty652JiVx-PydqryxEYiKRNoDUe5wYBfotOrRRMhm3RWmSQYlhvicgg90TOyWQdklKQbrY-zDMEIalHRDZRXAKDp4IKgDevSdqJ90W4tPsUS9thGfLPM6-nb__erbJrz5eXJ6dXuWqqkXKOSt5X3GtgHJeiDVnrOM9retKd7VuRF9DITjjHdUUJFRCCaXLqi_Q3Ul0H2ev571j8L8miKkdTFRgrXTgp9jyRlRlVRQIvvwHvPVTcHhbWzAmGl4XHKF8hlTwMQbo2zGYQYZ9y2h7KLqdi27nopF_sSydugH0Pb00i8CrBZBRSdvjPyoT7zkuKooocm9mzk_jfzOXG7FjuPsLy_ATH1s2dbu5-dGur6-vxacPtL0p_wCWUNT5</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>Papanikolaou, Evangelos G.</creator><creator>Bourgain, Claire</creator><creator>Kolibianakis, Efstratios</creator><creator>Tournaye, Herman</creator><creator>Devroey, Paul</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20050601</creationdate><title>Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes</title><author>Papanikolaou, Evangelos G. ; Bourgain, Claire ; Kolibianakis, Efstratios ; Tournaye, Herman ; Devroey, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-6136f46dce066289611b6f0554db5d78f5e28616b0d0eae48c8cd34f2458ba613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Chorionic Gonadotropin - therapeutic use</topic><topic>endometrial receptivity</topic><topic>Endometrium - drug effects</topic><topic>Endometrium - pathology</topic><topic>Endometrium - physiology</topic><topic>estrogen receptor</topic><topic>Female</topic><topic>Fertilization in Vitro - methods</topic><topic>Follicle Stimulating Hormone - therapeutic use</topic><topic>Follicular Phase - drug effects</topic><topic>Follicular Phase - physiology</topic><topic>GnRH antagonist</topic><topic>Gonadotropin-Releasing Hormone - antagonists &amp; inhibitors</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Luteal Phase - drug effects</topic><topic>Luteal Phase - physiology</topic><topic>Luteinizing Hormone - blood</topic><topic>Medical sciences</topic><topic>Ovulation Induction - methods</topic><topic>pre-ovulatory endometrium</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Pregnancy Rate</topic><topic>progesterone receptor</topic><topic>Prospective Studies</topic><topic>Receptors, Steroid - drug effects</topic><topic>Receptors, Steroid - metabolism</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Papanikolaou, Evangelos G.</creatorcontrib><creatorcontrib>Bourgain, Claire</creatorcontrib><creatorcontrib>Kolibianakis, Efstratios</creatorcontrib><creatorcontrib>Tournaye, Herman</creatorcontrib><creatorcontrib>Devroey, Paul</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Papanikolaou, Evangelos G.</au><au>Bourgain, Claire</au><au>Kolibianakis, Efstratios</au><au>Tournaye, Herman</au><au>Devroey, Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum. Reprod</stitle><addtitle>Hum. Reprod</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>20</volume><issue>6</issue><spage>1541</spage><epage>1547</epage><pages>1541-1547</pages><issn>0268-1161</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>BACKGROUND: Ovarian stimulation for IVF profoundly alters the early luteal phase endometrial development. It has been hypothesized that this process has already started in the late follicular phase, as the endometrium has already been exposed to high steroid concentrations since that phase. The aim of the present study was to prospectively investigate the effect of multi-follicular ovarian stimulation for IVF on the late follicular phase endometrium histology and the expression of estrogen receptor (ER) and progesterone receptor (PR). METHODS: In a cross-over study, 11 infertile women with normal ovulatory function, participating in an IVF programme and treated with GnRH antagonist/recombinant FSH ovarian stimulation, were enrolled in the study. Endometrial biopsies were taken in a natural cycle on the day of the onset of the surge of the LH, and in a subsequent stimulation cycle on the day of hCG administration for final oocyte maturation. Endometrial histological dating was carried out according to Noyes' criteria. Immunohistochemistry was performed, using commercially available antibodies for ER and PR endometrial expression. The immunohistochemical signal was recorded in 1000 epithelial cells in each compartment (glands and stroma). Endometrial expression for each of the two receptors was graded on a scale of 0–3, based on the intensity of nuclear staining. Then a score range between 0 and 3000 was recorded, and expressed as a mean score per 1000 stroma or glandular cells per sample (range: 0–3). RESULTS: Histological examination of biopsies both in natural and stimulated cycles showed no secretory changes. However, in stimulated cycles, PR expression was significantly up-regulated compared to natural cycles in both glands (1.67 versus 1.34, P&lt;0.05) and stroma (1.98 versus 1.62, P&lt;0.05), whereas ER was down-regulated in glands (1.15 versus 1.43, P&lt;0.05). In IVF cycles, the progesterone measurements, although within normal values (range 0.8–1.4 µg/l), were significantly higher than in natural cycles (0.99 vs 0.63 µg/l, respectively, P=0.008). An ongoing pregnancy rate of 37.5% was achieved in the stimulated cycles. DISCUSSION: Although the current study found no early secretory transformation in stimulated endometria before hCG administration, the ER and PR expression in these endometria is similar to the one described during the first days of the luteal phase in natural cycles. Supraphysiological concentrations of estradol and subtle progesterone rises in the late follicular phase might be responsible for this modulated steroid receptor profile. This phenomenon indicates accentuated maturation of the endometrium in IVF cycles from the pre-ovulatory phase onwards.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>15705618</pmid><doi>10.1093/humrep/deh793</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 2005-06, Vol.20 (6), p.1541-1547
issn 0268-1161
1460-2350
language eng
recordid cdi_proquest_miscellaneous_67843422
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects Adult
Biological and medical sciences
Chorionic Gonadotropin - therapeutic use
endometrial receptivity
Endometrium - drug effects
Endometrium - pathology
Endometrium - physiology
estrogen receptor
Female
Fertilization in Vitro - methods
Follicle Stimulating Hormone - therapeutic use
Follicular Phase - drug effects
Follicular Phase - physiology
GnRH antagonist
Gonadotropin-Releasing Hormone - antagonists & inhibitors
Gynecology. Andrology. Obstetrics
Humans
Luteal Phase - drug effects
Luteal Phase - physiology
Luteinizing Hormone - blood
Medical sciences
Ovulation Induction - methods
pre-ovulatory endometrium
Pregnancy
Pregnancy Outcome
Pregnancy Rate
progesterone receptor
Prospective Studies
Receptors, Steroid - drug effects
Receptors, Steroid - metabolism
Reference Values
title Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T10%3A24%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Steroid%20receptor%20expression%20in%20late%20follicular%20phase%20endometrium%20in%20GnRH%20antagonist%20IVF%20cycles%20is%20already%20altered,%20indicating%20initiation%20of%20early%20luteal%20phase%20transformation%20in%20the%20absence%20of%20secretory%20changes&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Papanikolaou,%20Evangelos%20G.&rft.date=2005-06-01&rft.volume=20&rft.issue=6&rft.spage=1541&rft.epage=1547&rft.pages=1541-1547&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/deh793&rft_dat=%3Cproquest_cross%3E857801441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211876526&rft_id=info:pmid/15705618&rft_oup_id=10.1093/humrep/deh793&rfr_iscdi=true